Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #35,701 to #35,750.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Nonclassic eicosanoid (2 revisions)
  2. Noncompaction cardiomyopathy chest x ray (2 revisions)
  3. Noncovalent (2 revisions)
  4. Noni (2 revisions)
  5. Nonmetal (2 revisions)
  6. Nonoxynol-9 (2 revisions)
  7. Nonpathogenic intestinal amebae infection case study one (2 revisions)
  8. Nonpathogenic intestinal amebae infection other diagnostic studies (2 revisions)
  9. Nonpathogenic intestinal amebae infection physical examination (2 revisions)
  10. Nonpathogenic intestinal amebae infection risk factors (2 revisions)
  11. Nonpathogenic intestinal amebae infection screening (2 revisions)
  12. Norethisterone acetate (2 revisions)
  13. Norfloxacin indications and usage (2 revisions)
  14. Norfloxacin labels and packages (2 revisions)
  15. Norma Restieaux (2 revisions)
  16. Normal distribution (2 revisions)
  17. Normetanephrine (2 revisions)
  18. Northern blot (2 revisions)
  19. Nosocomial infection case study one (2 revisions)
  20. Nosocomial infection chest x ray (2 revisions)
  21. Nosocomial infection classification (2 revisions)
  22. Nosocomial infection cost-effectiveness of therapy (2 revisions)
  23. Nosocomial infection differential diagnosis (2 revisions)
  24. Nosocomial infection future or investigational therapies (2 revisions)
  25. Nosocomial infection history and symptoms (2 revisions)
  26. Nosocomial infection laboratory findings (2 revisions)
  27. Nosocomial infection natural history, complications and prognosis (2 revisions)
  28. Nosocomial infection other diagnostic studies (2 revisions)
  29. Nosocomial infection other imaging findings (2 revisions)
  30. Nosocomial infection physical examination (2 revisions)
  31. Notch 3 (2 revisions)
  32. Notifiable disease (2 revisions)
  33. Novartis Foundation (2 revisions)
  34. Novel human coronavirus infection case study one (2 revisions)
  35. Novel human coronavirus infection cost-effectiveness of therapy (2 revisions)
  36. Novel human coronavirus infection future or investigational therapies (2 revisions)
  37. Novel human coronavirus infection other imaging findings (2 revisions)
  38. Novel human coronavirus infection risk factors (2 revisions)
  39. Novel human coronavirus infection screening (2 revisions)
  40. Novel human coronavirus infection secondary prevention (2 revisions)
  41. Nuchal scan (2 revisions)
  42. Nuclear cardiology (2 revisions)
  43. Nuclear envelope (2 revisions)
  44. Nuclear receptor related-1 protein (2 revisions)
  45. Nuclear transport (2 revisions)
  46. Nucleation (2 revisions)
  47. Nucleic acid test (2 revisions)
  48. Nucleobindin 2 (2 revisions)
  49. Nucleolar and spindle associated protein 1 (2 revisions)
  50. Nucleolin (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:FewestRevisions"